Detection of Plasma EGFR Mutations in NSCLC Patients with a Validated ddPCR Lung cfDNA Assay

Conclusions: We validated in this study that the ddPCR Lung cfDNA Assay is reliable for detection of EGFR mutations in lung cancers, in terms of analytical performance, clinical validity and utility.

Source: Journal of Cancer - December 14, 2019 Category: Cancer & Oncology Authors: Qiao-mei Guo, Lin Wang, Wen-jun Yu, Li-hua Qiao, Ming-na Zhao, Xiao-meng Hu, Ya-meng Sun, Sheng Ni, Yun-hua Xu, Jia-tao Lou Tags: Research Paper Source Type: research